Carol Burt - IQVIA Holdings Independent Director

IQV Stock  USD 204.02  2.20  1.09%   

Director

Ms. Carol J. Burt is Independent Director of the Company. She was a principal of BurtHilliard Investments since 2008. She also serves on the operating council and as a senior advisor to Consonance Capital Partners, a private equity firm focused on investing in the U.S. healthcare industry, which she joined in 2013. From 1997 to 2007, Ms. Burt was an executive officer of WellPoint, Inc., lastly as Senior Vice President, Corporationrationrate Finance and Development. From 1996 to 1997, Ms. Burt was Senior Vice President and Treasurer of American Medical Response. From 1981 to 1996, Ms. Burt held various positions at Chase Securities, lastly as founder, managing director and head of its Health Care Investment Banking Group. Ms. Burt currently serves on the board of directors of ResMed Inc. and WellDyneRx, LLC. She previously served on the boards of directors of Envision Healthcare, WellCare Health Plans, Inc., Vanguard Health Systems, Inc. and Transitional Hospitals Corporationrationration. Ms. Burt is a member of Women Corporationrationrate Directors. She most recently served as Chair of the Fortune 1000 Working Group for the Womens Leadership Foundation of Colorado and is currently Chair of the board for the Colorado Chapter of The Nature Conservancy since 2019.
Age 62
Tenure 5 years
Address 2400 Ellis Road, Durham, NC, United States, 27703
Phone919 998 2000
Webhttps://www.iqvia.com
Burt earned a Bachelor of Business Administration from the University of Houston, where she graduated magna cum laude. Because of her leadership experience and over 35 years of business experience in the health insurance, healthcare services and financial services industries and her experience serving on public company boards, we believe Ms. Burt is well qualified to serve on the Board.

IQVIA Holdings Management Efficiency

The company has Return on Asset of 0.0511 % which means that on every $100 spent on assets, it made $0.0511 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.22 %, implying that it generated $0.22 on every 100 dollars invested. IQVIA Holdings' management efficiency ratios could be used to measure how well IQVIA Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IQVIA Holdings' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to climb to 0.06 in 2024, whereas Return On Tangible Assets are likely to drop 0.1 in 2024. At this time, IQVIA Holdings' Non Currrent Assets Other are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.64 in 2024, whereas Non Current Assets Total are likely to drop slightly above 13.7 B in 2024.
IQVIA Holdings has 14.23 B in debt with debt to equity (D/E) ratio of 2.37, meaning that the company heavily relies on borrowing funds for operations. IQVIA Holdings has a current ratio of 0.88, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for IQVIA to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Peter NeupertLaboratory of
65
Martin MackayCharles River Laboratories
65
Thomas SaliceMettler Toledo International
61
JeanLuc BelingardLaboratory of
72
Linda BaddourWaters
62
George MilneCharles River Laboratories
77
Laurie GlimcherWaters
66
Michael KellyMettler Toledo International
64
Gary HendricksonWaters
64
Nancy AndrewsCharles River Laboratories
63
Elisha FinneyMettler Toledo International
59
Virginia WilsonCharles River Laboratories
66
JeanPaul MangeolleCharles River Laboratories
57
Jeffrey DavisLaboratory of
57
Robert WilliamsLaboratory of
72
Richard WallmanCharles River Laboratories
69
George LladoCharles River Laboratories
55
Robert BertoliniCharles River Laboratories
59
Richard FrancisMettler Toledo International
52
Stephen ChubbCharles River Laboratories
76
Richelle ParhamLaboratory of
53
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina. Iqvia Holdings operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. IQVIA Holdings (IQV) is traded on New York Stock Exchange in USA. It is located in 2400 Ellis Road, Durham, NC, United States, 27703 and employs 88,000 people. IQVIA Holdings is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

IQVIA Holdings Leadership Team

Elected by the shareholders, the IQVIA Holdings' board of directors comprises two types of representatives: IQVIA Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IQVIA. The board's role is to monitor IQVIA Holdings' management team and ensure that shareholders' interests are well served. IQVIA Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IQVIA Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Ari Bousbib, Chairman of the Board, President, Chief Executive Officer
Nicholas Childs, Senior Treasury
John Danhakl, Independent Director
Trudy Stein, Chief VP
Andrea Spannheimer, Global Research
Richard III, President Solutions
Walter Staub, President - Research and Development Solutions
Michael McDonnell, Chief Financial Officer, Executive Vice President
Andrew Markwick, VP Relations
Carol Burt, Independent Director
Jon Resnick, President Canada
John Leonard, Lead Independent Director
Keriann Cherofsky, Corporate VP
Gregg Dearhammer, Safety Sciences
Cynthia Verst, President Innovation
Jeffrey MD, Global VP
James Fasano, Independent Director
Ronald Bruehlman, Interim Chief Financial Officer, Executive Vice President
Jeffrey Spaeder, Global VP
Eric JD, General VP
John Connaughton, Independent Director
Colleen Goggins, Independent Director
Nilton Paletta, President America
Todd Sisitsky, Independent Director
Eric Sherbet, Executive Vice President General Counsel, Secretary
Costa Panagos, President - Research & Development Solutions
Lucas Glass, Global Excellence
Rob Kotchie, President Solutions
Wendy Stewart, President Operations
Kerri Joseph, SVP Treasury
Jim Berkshire, Executive Operations
Alistair Grenfell, Middle Europe
Karl Guenault, Senior Officer
Ronald Rittenmeyer, Independent Director
Brian Mi, President Pacific
Kevin Knightly, President - Information and Technology Solutions

IQVIA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IQVIA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IQVIA Stock Analysis

When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.